Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Telomir Pharmaceuticals, Inc. (TELO) had Return on Investments of -176.10% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-10.41M |
|
-- |
|
-- |
|
$10.54M |
|
$-10.54M |
|
$0.13M |
|
$-10.41M |
|
$-10.41M |
|
$-10.41M |
|
$-10.41M |
|
$-10.41M |
|
$-10.41M |
|
$-10.54M |
|
$-10.54M |
|
31.65M |
|
31.65M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$7.34M |
|
-- |
|
-- |
|
$7.34M |
|
$1.43M |
|
-- |
|
-- |
|
$1.43M |
|
$5.91M |
|
$5.91M |
|
$5.91M |
|
34.38M |
|
| Cash Flow Statement Financials | |
$-3.69M |
|
-- |
|
$9.71M |
|
$1.27M |
|
$7.29M |
|
$6.02M |
|
$5.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-176.10% |
|
-176.10% |
|
-141.84% |
|
|
Return on Investments |
-176.10% |
$0.17 |
|
$-0.12 |
|
$-0.12 |
|